#ASH13 - Twitter Hashtag

9 months ago

Whole Exome Sequencing [WES] Of Multiple Myeloma Reveals An Heterogeneous Clonal Architecture and Genomic Evolution [Nov 15, 2013] @nickbolli et al. @BloodJournal #ASH13 https://t.co/pAifRovnBA #mmsm #cagenome n=67 Pts; n=15 w/ 2-3 serial samples

0

3

0

195

Mike Thompson, MD, PhD, FASCO

@mtmdphd

10 months ago

Whole Exome Sequencing [WES] Of Multiple Myeloma Reveals An Heterogeneous Clonal Architecture and Genomic Evolution [Nov 15, 2013] @nickbolli et al. @BloodJournal #ASH13 https://t.co/pAifRovnBA #mmsm #cagenome n=67 Pts; n=15 w/ 2-3 serial samples

0

1

0

209

Mike Thompson, MD, PhD, FASCO

@mtmdphd

about 1 year ago

Whole Exome Sequencing [WES] Of Multiple Myeloma Reveals An Heterogeneous Clonal Architecture and Genomic Evolution [Nov 15, 2013] @nickbolli et al. @BloodJournal #ASH13 https://t.co/pAifRouPM2 #mmsm #cagenome n=67 Pts; n=15 w/ 2-3 serial samples

0

3

0

419

Mike Thompson, MD, PhD, FASCO

@mtmdphd

over 1 year ago

Whole Exome Sequencing [WES] Of Multiple Myeloma Reveals An Heterogeneous Clonal Architecture and Genomic Evolution [Nov 15, 2013] @nickbolli et al. @BloodJournal #ASH13 https://t.co/pAifRovnBA #mmsm #cagenome n=67 Pts; n=15 w/ 2-3 serial samples

1

4

1

0

408

Naveen Pemmaraju, MD @doctorpemm

over 2 years ago

#ASH23 Lovely to get to see the brilliant Dr .@jyoti_nangalia & chat about the future of #CALR & #MPNSM on the exact 10th anniversary of her ground-breaking #CALR @NEJM paper which was @ASH_hematology LBA from #ASH13 !! https://t.co/PuEvD1HVW4 @NitinJainMD @harrisoncn1 @mpdrc 👏

doctorpemm's tweet photo. #ASH23 Lovely to get to see the brilliant Dr .@jyoti_nangalia & chat about the future of #CALR & #MPNSM on the exact 10th anniversary of her ground-breaking #CALR @NEJM paper which was @ASH_hematology LBA from #ASH13 !! https://t.co/PuEvD1HVW4 @NitinJainMD @harrisoncn1 @mpdrc 👏 https://t.co/Yj9ViUDdPl

0

24

0

1K

Jacob Plieth

@JacobPlieth

over 3 years ago

9 years after Tefferi and #ASH13 imetelstat scores in Imerge. But in what precise setting might it be used? Via @evaluatevantage -> https://t.co/sD2xPuNSU4 $GERN $BMY

5

11

3

20K

Andres Gomez

@GomezDLeonMD

over 3 years ago · New Orleans

@Dr_AmerZeidan @ASH_hematology My first was #ASH13 here in #NOLA, as a research intern. Couldn’t understand much but I loved it. Went to a saints game… almost 10 years ago 👴🏻#ASH22

0

3

0

Amer Zeidan عامر زيدان

@Dr_AmerZeidan

over 3 years ago

Nine years between the 2 photos in #ASH13 & #ASH22 but dr Peter Greenberg remains one of my favorite #MDSsm heros

3

48

0

1

0

Jacob Plieth

@JacobPlieth

over 3 years ago

Who remembers #ASH13 (coincidentally also in New Orleans)? After the clinical hold, $JNJ deal/no deal etc, I really didn't think I'd still be writing about $GERN at #ASH22

Jacob Plieth

@JacobPlieth

over 12 years ago

Tefferi - 23% CR/PR "never seen before". Here's his summary of JAKs $GERN #ASH13

1

4

0

2

6

2

0

Sally Church @MaverickNY

over 6 years ago

An update on BTK in CLL has been added for subs now that we know J&J have filed ibrutinib in 1L CLL. Astonishingly, it all relates back to a talk from #ASH13 - lovely to come back full circle and answer a key question posed then...

Sally Church @MaverickNY

over 6 years ago

It's that time of the year for our first #ASH19 Preview - we look at BTK inhibitors, highlight a newcomer in this niche who look promising and explain why. Are you ready for the ruck and maul in the poster scrum...?! https://t.co/SGkgSUCblt